Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

EMTN Programme Supplementary Prospectus

1 Jul 2025 12:55

RNS Number : 2446P
Sainsbury(J) PLC
01 July 2025
 

1 July 2025

 

EMTN PROGRAMME PUBLICATION OF SUPPLEMENTARY PROSPECTUS

J Sainsbury plc

(the "Company")

 

The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

The supplementary prospectus dated 1 July 2025 (the "Supplementary Prospectus") supplementing the base prospectus (the "Prospectus") dated 17 January 2025 relating to the establishment of the £5,000,000,000 Euro Medium Term Note Programme, with J Sainsbury plc as the issuer.

 

The Supplementary Prospectus incorporates by reference the audited financial statements of the Company for the 52-week period ended on 1 March 2025.

 

The Supplementary Prospectus should be read and construed in conjunction with the Prospectus.

 

The full document can be viewed at: http://www.rns-pdf.londonstockexchange.com/rns/2446P_1-2025-7-1.pdf

 

A copy of the Prospectus has been submitted to the Financial Conduct Authority's Electronic Submission Service and may shortly be viewed on the National Storage Mechanism (NSM) at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

J Sainsbury plc LEI Number: 213800VGZAAJIKJ9Y484

 

Enquiries

Investor Relations Media

James Collins Rebecca Reilly

 +44 (0) 7801 813 074 +44 (0) 20 7695 7295

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. The Prospectus is not intended for use in the United States and is not addressed or targeted at U.S. persons and should not be relied upon by any U.S. person. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFFLFBEDLZBBX
Date   Source Headline
17th Feb 20232:15 pmRNSDirector/PDMR Shareholding
7th Feb 20239:00 amRNSDirector/PDMR Shareholding
1st Feb 20233:30 pmRNSBlock listing Interim Review
1st Feb 20231:35 pmRNSTotal Voting Rights
1st Feb 20238:15 amRNSHolding(s) in Company
30th Jan 202312:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:03 amRNSResponse to Bestway Group Announcement
27th Jan 20237:00 amRNSAcquisition of shares in J Sainsbury plc
20th Jan 20233:50 pmRNSDirector/PDMR Shareholding
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
11th Jan 20239:36 amRNSQ3 Trading Statement - Replacement
11th Jan 20237:00 amRNSQ3 Trading Statement
3rd Jan 20231:35 pmRNSTotal Voting Rights
23rd Dec 202212:15 pmRNSDirector/PDMR Shareholding
12th Dec 20229:15 amRNSDirector/PDMR Shareholding
1st Dec 202211:35 amRNSTotal Voting Rights
25th Nov 202212:30 pmRNSDirector/PDMR Shareholding
10th Nov 202211:00 amRNSDirector/PDMR Shareholding
9th Nov 20224:00 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSHalf-year Report
1st Nov 20223:00 pmRNSTotal Voting Rights
28th Oct 20224:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
30th Sep 20223:20 pmRNSDirector/PDMR Shareholding
26th Sep 20227:06 amRNSProperty Transaction Update
21st Sep 202210:01 amRNSProperty Transactions
7th Sep 20224:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20221:05 pmRNSDirector/PDMR Shareholding
1st Sep 202212:45 pmRNSTotal Voting Rights
5th Aug 20223:45 pmRNSDirector/PDMR Shareholding
1st Aug 20224:31 pmRNSBlock listing Interim Review
1st Aug 20222:45 pmRNSTotal Voting Rights
21st Jul 20229:00 amRNSAdditional Listing
8th Jul 20224:20 pmRNSDirector/PDMR Shareholding
7th Jul 20222:30 pmRNSResults of AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Statement
1st Jul 20221:45 pmRNSTotal Voting Rights
10th Jun 20225:20 pmRNSDirector/PDMR Shareholding
6th Jun 20223:00 pmRNSDirector/PDMR Shareholding
6th Jun 20221:15 pmRNSAnnual Report and Notice of AGM 2022
1st Jun 202211:45 amRNSTotal Voting Rights
13th May 20222:30 pmRNSDirector/PDMR Shareholding
12th May 20224:30 pmRNSDirector/PDMR Shareholding
3rd May 20225:20 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSFinal Results
19th Apr 20222:15 pmRNSDirector/PDMR Shareholding
14th Apr 20227:00 amRNSDirectorate Changes
1st Apr 20221:15 pmRNSTotal Voting Rights
18th Mar 20222:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.